Francesco Campo

Dr. Francesco Campo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GSGiuseppe Sgarito
Giuseppe Sgarito
FCFrancesco Campo
Francesco Campo
SSSergio Sciacca
Sergio Sciacca
MPMichele Pilato
Michele Pilato
MCManlio Cipriani
Manlio Cipriani
Sergio ContiSergio Conti
Sergio Conti
Ventricular arrhythmias (VAs) are common and clinically important complications in patients supported by left ventricular assist devices (LVADs), occurring in up to 50% of cases within the first year after implantation. Despite the hemodynamic support provided by LVADs, VAs are linked to increased morbidity and mortality, primarily through recurrent implantable cardioverter defibrillator (ICD) shocks and right ventricular failure. The underlying mechanisms of VAs in this population are multifactorial, involving structural myocardial remodeling, device-related factors, and pre-existing arrhythmic substrates. Catheter ablation has become a valuable treatment option when antiarrhythmic drug therapy and device reprogramming are inadequate, though procedural timing (pre-, intra-, or post-implantation) and approaches remain under discussion. Epicardial access during LVAD surgery may provide advantages for selected patients, while ablation after implantation poses technical challenges due to altered anatomy and electromagnetic interference. This review offers a comprehensive overview of the epidemiology, pathophysiology, risk stratification, and management of VAs in LVAD recipients, emphasizing technical considerations, procedural safety, and clinical outcomes of catheter ablation. A multidisciplinary approach remains essential in guiding personalized treatment and optimizing outcomes for this complex population. Undergoing studies will provide more insight into optimal management of arrhythmias, particularly regarding the optimal timing of catheter ablation. The impact of new technologies such as non-invasive mapping alongside pre-procedural imaging needs also to be further evaluated.

8 January 2026 in Hearts
Verified
Journal Article
Open access
PDF file
GSGiuseppe Sgarito
Giuseppe Sgarito
FCFrancesco Campo
Francesco Campo
DGDavide Genovese
Davide Genovese
Giacomo MugnaiGiacomo Mugnai
Giacomo Mugnai
Francesco SantoroFrancesco Santoro
Francesco Santoro
Sergio ContiSergio Conti
Sergio Conti
The role of cardiac implantable electronic devices (CIEDs), including implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices, in patients supported with left ventricular assist devices (LVADs) remains controversial. Although ICDs clearly reduce the risk of sudden cardiac death (SCD) and improve outcomes in advanced heart failure (HF), their benefit in patients with continuous-flow mechanical circulatory support is less certain. Initial small studies involving LVAD patients, particularly those with older pulsatile devices, suggested that ICDs confer a survival benefit during LVAD support. However, more recent evidence has been inconsistent. Some studies show modest protection against arrhythmic death, whereas others show no improvement in overall mortality. Similarly, CRT does not appear to offer significant additional hemodynamic benefits after LVAD implantation, and current evidence does not strongly support its routine continuation. Device-related complications—including lead failure, infection, electromagnetic interference, and inappropriate shocks—are major clinical concerns that can offset potential benefits. Accordingly, current guidelines recommend maintaining pre-existing ICD or CRT devices in LVAD patients but do not endorse the routine implantation of new devices after LVAD placement. The existing evidence highlights the need for a nuanced and individualized approach to CIED therapy in patients with LVAD. Future research should focus on randomized trials, registry-based analyses, and the exploration of novel technologies such as leadless pacing, subcutaneous ICDs, and advanced programming algorithms. Patient-centered outcomes, particularly quality of life and ethical considerations—such as ICD deactivation in end-of-life scenarios—must be considered in decision-making in this evolving field.

12 March 2026 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
GRGiulio La Rosa
Giulio La Rosa
GPGemma Pelargonio
Gemma Pelargonio
Francesco SantoroFrancesco Santoro
Francesco Santoro
Sergio ContiSergio Conti
Sergio Conti
FCFrancesco Campo
Francesco Campo
GSGiuseppe Sgarito
Giuseppe Sgarito
Takotsubo syndrome (TTS) is a temporary and reversible form of cardiomyopathy that clinically mimics acute coronary syndrome, typically triggered by intense physical or emotional stress. It mainly affects postmenopausal women and exhibits significant variation among individuals regarding its onset, progression, and outcomes. Although significant advances have been made since its initial description in 1990, the underlying pathophysiological mechanisms remain incompletely understood, limiting the development of effective prevention and targeted treatment strategies. A potential genetic predisposition has been suggested, supported by reports of familial clustering; however, a systematic and updated characterization of genetic and epigenetic factors associated with TTS is still lacking. This systematic and critical review aims to offer a comprehensive overview of current evidence on genetic susceptibility and epigenetic biomarkers potentially involved in the pathogenesis of TTS. Due to the heterogeneity and inconsistency of available findings, particular attention is also given to the methodological limitations of existing genetic studies. Finally, the review examines emerging multimodal approaches that may offer new perspectives for understanding the complex biological foundations of this syndrome.

24 September 2026 in Heart Rhythm
Verified
Journal Article
Open access
Francesco SantoroFrancesco Santoro
Francesco Santoro
FNFrancesco Paolo Niglio
Francesco Paolo Niglio
PPPietro Palmisano
Pietro Palmisano
MMMartina Molinari
Martina Molinari
GSGiuseppe Sgarito
Giuseppe Sgarito
NBNatale Daniele Brunetti
Natale Daniele Brunetti